Capsule Commentary on Anthenelli et al., Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

Lignende værker

• Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
  af: Anthenelli, Robert M., et al.
  Udgivet: (2019)
• Varenicline, Smoking Cessation and Neuropsychiatric Adverse Events
  af: Gibbons, Robert D., et al.
  Udgivet: (2013)
• Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES
  af: West, Robert, et al.
  Udgivet: (2018)
• Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events
  af: Keeney, Edna, et al.
  Udgivet: (2021)
• Smoking cessation and neuropsychiatric adverse events: Are family physicians caught between a rock and a hard place?
  af: Els, Charl, et al.
  Udgivet: (2011)